Thymosin β4 suppresses CCl4 -induced murine hepatic fibrosis by down-regulating transforming growth factor β receptor-II
Author:
Affiliation:
1. Department of Rheumatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an; Shaanxi Province China
2. Department of Gastroenterology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an; Shaanxi Province China
Funder
National Natural Science Foundation of China
Publisher
Wiley
Subject
Genetics(clinical),Drug Discovery,Genetics,Molecular Biology,Molecular Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/jgm.3043/fullpdf
Reference43 articles.
1. Thymosin beta4: structure, function, and biological properties supporting current and future clinical applications;Crockford;Ann N Y Acad Sci,2010
2. Thymosin beta4 expression in human tissues and in tumors using tissue microarrays;Jo;Appl Immunohistochem Mol Morphol,2011
3. Thymosin beta4 and its posttranslational modifications;Hannappel;Ann N Y Acad Sci,2010
4. The beta-thymosins: intracellular and extracellular activities of a versatile actin binding protein family;Mannherz;Cell Motil Cytoskeleton,2009
5. Internalization is essential for the antiapoptotic effects of exogenous thymosin beta-4 on human corneal epithelial cells;Ho;Invest Ophthalmol Vis Sci,2007
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In Vitro Study of Thymosin Beta 4 Promoting Transplanted Fat Survival by Regulating Adipose-Derived Stem Cells;Aesthetic Plastic Surgery;2024-02-26
2. Mechanism of thymosin β4 in ameliorating liver fibrosis via the MAPK/NF‐κB pathway;Journal of Biochemical and Molecular Toxicology;2023-05-21
3. Thymosin β4 and the anti-fibrotic switch;International Immunopharmacology;2023-02
4. 0.1% RGN-259 (Thymosin ß4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical Trial;International Journal of Molecular Sciences;2022-12-29
5. The Role of Tβ4-POP-Ac-SDKP Axis in Organ Fibrosis;International Journal of Molecular Sciences;2022-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3